1 e value and use of this probe to select
anti-
delta9-THC antibodies that bind delta9-THC with good aff
2 a nonspatial operant task and can
attenuate delta9-THC- induced behavioral deficits.
3 ay facilitate future binding studies
between delta9-THC and its analogues and the cannabinoid recepto
4 select anti-delta9-THC antibodies that
bind delta9-THC with good affinity.
5 ith long-term exposure (approximately 18
h),
delta9-THC also desensitizes CB1 receptors.
6 Estrogen also attenuated the ability
of delta9-THC (0.56- 3.2 mg/kg) to decrease response accura
7 erminal carbons and the pentyl side chain
of delta9-THC, and (4) the polyolefin loop overlaying with
8 This effect
of delta9-THC may have implications in treatment of gastro-
9 tial gastrointestinal therapeutic effects
of delta9-THC are less well-known.
10 Here, we report a role
of delta9-THC in a vago-vagal reflex that can result in gas
11 cribe a convenient synthesis of
radiolabeled delta9-THC.
12 The synthetic route to
radiolabeled delta9-THC has enabled the correct assessment of the aff
13 The effect of
systemic delta9-THC on gastric distention-evoked LOS relaxation w
14 Delta9-
Tetrahydrocannabinol (
delta9-THC) fails to inhibit EPSCs, yet readily occludes
15 Delta9-
tetrahydrocannabinol (
delta9-THC) is an effective anti-emetic; however, other
16 of estrogen and delta9-
tetrahydrocannabinol (
delta9-THC) on learning and memory in ovariectomized rat
17 y for (-)-trans-delta9-
tetrahydrocannabinol (
delta9-THC).
18 in marijuana is delta9-
tetrahydrocannabinol (
delta9-THC); hence, monoclonal antibodies with high affi
19 These novel findings suggest
that delta9-THC can modulate reflex LOS function and that the
20 that induce an effective immune response
to delta9-THC and describe a convenient synthesis of radiol
21 avored an optimal pharmacophore overlay
with delta9-THC.